Skye Bioscience, Inc. Increase (Decrease) in Due to Other Related Parties, Current
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Due to Other Related Parties, Current of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOtherRelatedPartiesCurrent · last filed 2025-03-20
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2024-12-31 was $0.00.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2024-09-30 was $0.00.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for the quarter ending 2024-03-31 was $0.00.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for fiscal 2024 was $0.00.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for fiscal 2023 was -$95.85K, a 200.00% decline from fiscal 2022.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for fiscal 2022 was $95.85K.
- Skye Bioscience, Inc. increase (decrease) in due to other related parties, current for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Due to Other Related Parties, Current 3 month | Increase (Decrease) in Due to Other Related Parties, Current 3 month as first filed | Increase (Decrease) in Due to Other Related Parties, Current 6 month | Increase (Decrease) in Due to Other Related Parties, Current 6 month as first filed | Increase (Decrease) in Due to Other Related Parties, Current 9 month | Increase (Decrease) in Due to Other Related Parties, Current 9 month as first filed | Increase (Decrease) in Due to Other Related Parties, Current 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | -$1.77K derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$1.77K derived: sum of 3 quarters · filed 2025-03-20 | $0.00 derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$1.77K derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | -$95.85K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$1.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | -$95.85K 10-Q · filed 2024-11-07 | -$102.39K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $1.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$94.08K 10-Q · filed 2024-08-09 | -$100.62K derived: sum of 3 quarters · filed 2024-08-09 | -$53.90K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$95.85K 10-Q · filed 2024-05-10 | -$102.39K derived: sum of 2 quarters · filed 2024-05-10 | -$55.67K derived: sum of 3 quarters · filed 2024-05-10 | $0.00 derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$6.54K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $40.18K derived: sum of 2 quarters · filed 2024-03-22 | $95.85K derived: sum of 3 quarters · filed 2024-03-22 | $95.85K 10-K · filed 2024-03-22 | |||
| 2022-09-30 | $46.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $102.39K derived: sum of 2 quarters · filed 2023-11-14 | $102.39K 10-Q · filed 2023-11-14 | $130.82K 10-Q · filed 2022-11-14 | $15.65K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $55.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $55.67K 10-Q · filed 2023-08-07 | $86.74K 10-Q · filed 2022-08-15 | -$31.07K derived: sum of 3 quarters · filed 2023-08-07 | $13.02K derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $43.13K 10-Q · filed 2022-05-06 | -$86.74K derived: sum of 2 quarters · filed 2023-05-12 | -$42.65K derived: sum of 3 quarters · filed 2023-05-12 | $958.00 derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$86.74K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$42.65K derived: sum of 2 quarters · filed 2023-03-31 | $958.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $44.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $87.69K derived: sum of 2 quarters · filed 2022-11-14 | $86.74K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $43.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $42.65K 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | -$958.00 10-Q · filed 2022-05-06 | ||||||
| 2020-09-30 | $44.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $46.17K derived: sum of 2 quarters · filed 2021-11-10 | $81.81K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $2.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $37.73K 10-Q · filed 2021-08-06 | |||||
| 2020-03-31 | $35.65K 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |